Early use of steroid-sparing agents in the inactivation of moderate-to-severe active thyroid eye disease: a step-down approach

scientific article published on 11 September 2018

Early use of steroid-sparing agents in the inactivation of moderate-to-severe active thyroid eye disease: a step-down approach is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/CEN.13834
P698PubMed publication ID30103255

P50authorZuzana SipkovaQ89403840
P2093author name stringJonathan H Norris
Helen E Turner
Shay Keren
Joel David
Elizabeth A Insull
P433issue6
P921main subjecteye diseaseQ3041498
P304page(s)834-839
P577publication date2018-09-11
P1433published inClinical EndocrinologyQ15762781
P1476titleEarly use of steroid-sparing agents in the inactivation of moderate-to-severe active thyroid eye disease: a step-down approach
P478volume89

Reverse relations

cites work (P2860)
Q98770781A Review of Clinical Applications and Side Effects of Methotrexate in Ophthalmology
Q91826689Step-down steroid-sparing therapy in active thyroid eye disease

Search more.